quinuclidines has been researched along with ifosfamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trissel, LA; Xu, QA | 1 |
| Guo, JX; Huang, XE; Liu, J; Liu, YC; Wei, W; Xiao, Y | 1 |
1 trial(s) available for quinuclidines and ifosfamide
| Article | Year |
|---|---|
Phase II study on EANI combined with hydrochloride palonosetron for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Electric Stimulation Therapy; Epirubicin; Humans; Ifosfamide; Isoquinolines; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Vomiting; Young Adult | 2014 |
1 other study(ies) available for quinuclidines and ifosfamide
| Article | Year |
|---|---|
Compatibility of palonosetron with cyclophosphamide and with ifosfamide during simulated Y-site administration.
Topics: Antiemetics; Antineoplastic Agents, Alkylating; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cyclophosphamide; Drug Stability; Glucose; Ifosfamide; Infusions, Intravenous; Isoquinolines; Palonosetron; Pharmaceutical Solutions; Quinuclidines | 2005 |